Phase 4 N=188 Randomized Single-blind Treatment

Treatment for Post-Stroke Depression

Stroke · Depression

Bottom Line

View on ClinicalTrials.gov: NCT00029172 ↗

Enrolled (actual)

188

Serious AEs

0.0%

Results posted

Jan 2010

Primary outcome: Primary: Twelve Week Depression Outcomes — 10.6 HAM-D depression score

Study Design & Population

Study type: Interventional
Phase: Phase 4
Interventions: case management (Other)
Age: Pediatric, Adult, Older Adult
Sex: All
Sponsor: Indiana University
Primary completion: —

Outcome Measures

Outcome	Result	p-value
PRIMARY Twelve Week Depression Outcomes	10.6	—

Summary

The purpose of this study is to evaluate a program of education, medicine, and monitoring for the treatment of depression after a stroke.

Eligibility Criteria

No severe language or cognitive deficits,
life expectancy of at least 9 months, and
willingness to participate.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00029172). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.